Limitations, agreements, and source contact

Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma · Source last updated 2018-02-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

Michael.Grossbard@nyumc.org

organization

New York University School of Medicine

phone

646 501 9305

title

Michael Grossbard, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice